Fig. 1From: ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella screening trial of maintenance targeted therapy after chemotherapy in patients with advanced or metastatic urothelial cancerStudy design for patients in ATLANTIS trial. Abbreviations: MET MET proto-oncogene, PFS progression-free survival, VEGF vascular endothelial growth factorBack to article page